Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000038777-26-000276·Contineum Therapeutics, Inc.
Schedule 13G ownership disclosure
Contineum Therapeutics Inc
Class A Common Stock, $0.001 par value per share · CUSIP: 21217B100
Event date: 2026-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Franklin Templeton, Inc.
Shares: 1,704,550.00 · Class: 5.2%
- Charles B. Johnson
Shares: 0.00 · Class: 0%
- Rupert H. Johnson, Jr.
Shares: 0.00 · Class: 0%
- Franklin Advisers, Inc.
Shares: 1,704,550.00 · Class: 5.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000038777-26-000276
- Form type
- SCHEDULE 13G/A
- Filer
- Contineum Therapeutics, Inc.
- CIK
- CIK 1855175
- Filed
- Oct 28, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership